Year: 2025

PERTH, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKEF) (‘Alkane’ or ‘the Company’) will release its Q1 FY2026 Operating Financial Results on 13 November 2025. Following this, the Managing Director & CEO, Mr Nic Earner, and CFO, Mr James Carter, will host a conference call and webcast to discuss these results. Details to participate are as follows:Date/Time: Canada     4:00pm EST, Thursday 13 November 2025     Australia     8:00am AEDT, Friday 14 November 2025   Conference Call Registration: https://register-conf.media-server.com/register/BI3d02ff95f1dd48b2bf6b3d377ac0d0c5   Webcast Link: https://edge.media-server.com/mmc/p/5a78wc3qThe presentation relating to this webcast will be available on the Company website at alkres.com. Investors...

BROADVIEW, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a national seller of gourmet specialty foods, today announced the timing for a call with investors to discuss third quarter 2025 financial results. The Company will publish its Third Quarter 2025 financial results on Friday, November 14, 2025 and host an investor conference call on Monday, November 17, 2025 at 4:00 PM Eastern Time to discuss results for the quarter ended September 30, 2025. Interested participants may join the call online or by phone using the access information below. A Q&A segment will follow the prepared remarks, addressing questions submitted in advance. To submit question, email investorrelations@ivfh.com with the subject “Q3 Earnings Q&A” by Sunday, November 16, 2025, 12:00 PM...

BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $21.50 per ADS. The aggregate gross proceeds to Centessa from this offering are expected to be approximately $250 million, before deducting underwriting discounts and commissions and offering expenses payable by Centessa. All ADSs sold in the offering were offered by Centessa. The offering is expected to close on or about November 14, 2025, subject to customary closing conditions. Centessa has also granted the underwriters a 30-day option to purchase up to an additional 1,744,186 ADSs at the public offering price, less...

PHILADELPHIA, Nov. 11, 2025 (GLOBE NEWSWIRE) — via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in data monetization, credentialing, and digital engagement technologies, completed a series of Veterans Week events in Washington, D.C., where it presented its Valor Preservation Coin and VerifyU™ credential-verification platform to policymakers, veterans, and industry partners. On November 9, 10 and 11, Datavault AI participated in the Grand Marshal Dinner at the Ronald Reagan International Trade Center, the Third Annual Veterans Day Parade, and a Technology Demonstration at the Phoenix Park Hotel, respectively. These events advanced the Company’s national visibility and highlighted its growing role in building trusted, government-grade systems that protect authenticity and preserve verified identity. The Valor Preservation...

Paris, November 11, 2025 – Pluxee takes note of the communication issued by the Brazilian government concerning the Workers’ Food Program (Programa de Alimentação do Trabalhador – PAT), introducing changes to the merchant discount rate (MDR), reimbursement deadlines, and voucher processing. These measures, set to start taking effect in 90 days at the earliest, diverge significantly from the discussions previously conducted between the industry association (ABBT) and the government. Pluxee is concerned that these provisions could compromise the long-term sustainability of the PAT, notably with an increased risk of misuse, non-compliance, and unbalanced credit positions specifically with public clients. Since the PAT creation, and for over 40 years, Pluxee has contributed to the program’s expansion by developing innovative solutions and...

TEL AVIV, Israel, Nov. 11, 2025 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE) (“REE”), an automotive technology company developing software-defined vehicle technology, today announced the release of a supplement (the “Supplement”) to its proxy statement dated October 9, 2025 (the “Proxy Statement”). The Proxy Statement was prepared in connection with a special general meeting of shareholders of the Company to be held on Thursday, November 13, 2025 at 12:00 p.m. Israel time (5:00 a.m. Eastern Time), at REE’s headquarters at Kibbutz Glil-Yam, Israel. REE encourages shareholders to review the Supplement. The Proxy Statement and the Supplement are, or will be, available for review on the “investor relations” section of REE’s website at https://investors.ree.auto/ as well as at the U.S. Securities and Exchange Commission website...

IRVINE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. All of the shares and pre-funded warrants in the proposed offering will be offered by Eledon. In addition, Eledon intends to grant the underwriters a 30-day option to purchase up to a number of additional shares of common stock equal to 15% of the total number of shares of common stock (and shares of common stock underlying pre-funded warrants) sold in the public offering, on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering...